These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33043447)

  • 1. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
    Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
    Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
    Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
    Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
    Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
    Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
    Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
    Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients.
    Drácz B; Czompa D; Müllner K; Hagymási K; Miheller P; Székely H; Papp V; Horváth M; Hritz I; Szijártó A; Werling K
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
    Yin G; Man C; Liao S; Qiu H
    Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
    Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
    Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
    Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversed De Ritis ratio for predicting in-hospital mortality among intensive care patients with organophosphate poisoning.
    Nafea O; Ibrahim F; Abdelhamid W
    Biomarkers; 2023 Feb; 28(1):111-117. PubMed ID: 36377078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
    Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
    Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
    Ahmadabad MA; Naeimi A; Keymoradzadeh A; Faghani S; Ahmadabad MA; Boroujeni NA; Mohammadpour H; Saberi A
    BMC Neurol; 2022 Dec; 22(1):450. PubMed ID: 36463106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-Ritis Ratio Is Associated with Mortality after Cardiac Arrest.
    Lu Z; Ma G; Chen L
    Dis Markers; 2020; 2020():8826318. PubMed ID: 33204363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Significant Prognostic But Not Predictive Biomarker in Japanese Patients with Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel.
    Miyake H; Matsushita Y; Watanabe H; Tamura K; Suzuki T; Motoyama D; Ito T; Sugiyama T; Otsuka A
    Anticancer Res; 2018 Jul; 38(7):4179-4185. PubMed ID: 29970547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Study of De Ritis (Ast/ Alt) Ratio in Comparision with Other Parameters for Predicting Poor Prognosis in Covid 19 Patients.
    A Y; R V
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
    Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
    Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of De Ritis ratio with aspartate aminotransferase and alanine aminotransferase within the reference range.
    Ndrepepa G; Holdenrieder S; Kastrati A
    Clin Chim Acta; 2023 Jan; 538():46-52. PubMed ID: 36370837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
    Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
    Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Ritis ratio and biochemical parameters in COVID-19 patients.
    Yazar H; Kayacan Y; Ozdin M
    Arch Physiol Biochem; 2022 Dec; 128(6):1676-1680. PubMed ID: 32683882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
    Kang M; Yu J; Sung HH; Jeon HG; Jeong BC; Park SH; Jeon SS; Lee HM; Choi HY; Seo SI
    Int J Urol; 2018 Jun; 25(6):596-603. PubMed ID: 29756394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.